Gene: B3GAT1
Official Full Name: beta-1,3-glucuronyltransferase 1provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the glucuronyltransferase gene family. These enzymes exhibit strict acceptor specificity, recognizing nonreducing terminal sugars and their anomeric linkages. This gene product functions as the key enzyme in a glucuronyl transfer reaction during the biosynthesis of the carbohydrate epitope HNK-1 (human natural killer-1, also known as CD57 and LEU7). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27841 | B3GAT1 Knockout cell line (HEK293) | Human | B3GAT1 | 1:3~1:6 | Negative | Online Inquiry |
B3GAT1 Gene Knockout Cell Lines are sophisticated biological tools designed to elucidate the function of the B3GAT1 gene, which is integral to glycosaminoglycan biosynthesis. This gene encodes an enzyme known as beta-1,3-glucuronyltransferase 1, involved in the modification of glycosaminoglycans, a crucial component of the extracellular matrix that influences cellular behavior. By employing CRISPR/Cas9 technology, these knockout cell lines completely abrogate B3GAT1 expression, facilitating researchers in investigating the gene’s role in various physiological and pathological processes, such as cell signaling, development, and disease.
The functionality of these knockout cell lines is evidenced by their ability to provide insights into how the absence of B3GAT1 affects cell morphology, proliferation, and interaction with the extracellular matrix. By examining these alterations, researchers can better understand diseases associated with glycosaminoglycan dysregulation, including certain cancers and congenital disorders. The application of B3GAT1 Gene Knockout Cell Lines extends not only to basic research but also to translational studies, offering potential pathways for therapeutic interventions.
One distinct advantage of these cell lines is their precision; unlike alternative gene modification methods, CRISPR technology enables specific and targeted gene knockout without the introduction of off-target effects, ensuring the integrity of the research findings. Additionally, the convenience of working with a readily available knockout model accelerates the timeline for experimental design and execution.
Researchers and clinicians alike will appreciate the value of B3GAT1 Gene Knockout Cell Lines in their projects, as they represent a significant leap forward in the study of genetic regulation and its implications in health and disease. Our company, known for its commitment to advancing genetic research through innovative biological products, is proud to offer these knockout cell lines, backed by rigorous scientific validation and technical support.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.